Jennifer Rose Gatchel, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 27 | 2024 | 8601 | 1.870 |
Why?
|
| Apathy | 4 | 2024 | 107 | 1.680 |
Why?
|
| tau Proteins | 12 | 2024 | 2095 | 1.010 |
Why?
|
| Amyloid beta-Peptides | 16 | 2024 | 3839 | 0.960 |
Why?
|
| Positron-Emission Tomography | 22 | 2024 | 6485 | 0.920 |
Why?
|
| Depression | 9 | 2024 | 8124 | 0.780 |
Why?
|
| Presenilin-1 | 6 | 2023 | 660 | 0.720 |
Why?
|
| Entorhinal Cortex | 3 | 2023 | 287 | 0.570 |
Why?
|
| Amyloid | 5 | 2024 | 841 | 0.550 |
Why?
|
| Geriatric Psychiatry | 2 | 2023 | 71 | 0.510 |
Why?
|
| Neurosyphilis | 1 | 2015 | 27 | 0.490 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 2 | 2019 | 28 | 0.470 |
Why?
|
| Amyloidosis | 1 | 2020 | 817 | 0.450 |
Why?
|
| Temporal Lobe | 3 | 2019 | 1695 | 0.440 |
Why?
|
| Mental Disorders | 4 | 2023 | 6845 | 0.410 |
Why?
|
| Spinocerebellar Ataxias | 3 | 2008 | 105 | 0.410 |
Why?
|
| Aging | 5 | 2024 | 8711 | 0.410 |
Why?
|
| Antipsychotic Agents | 2 | 2023 | 3067 | 0.390 |
Why?
|
| Parietal Lobe | 1 | 2017 | 852 | 0.380 |
Why?
|
| Agnosia | 2 | 2020 | 66 | 0.340 |
Why?
|
| Neuropsychological Tests | 11 | 2022 | 7054 | 0.340 |
Why?
|
| Longitudinal Studies | 11 | 2024 | 14607 | 0.330 |
Why?
|
| Memory Disorders | 3 | 2020 | 1199 | 0.310 |
Why?
|
| Brain | 14 | 2024 | 27121 | 0.300 |
Why?
|
| Somatomedins | 1 | 2008 | 179 | 0.290 |
Why?
|
| Cognition Disorders | 2 | 2019 | 3980 | 0.270 |
Why?
|
| Aged | 34 | 2024 | 169308 | 0.270 |
Why?
|
| Aniline Compounds | 7 | 2021 | 1069 | 0.260 |
Why?
|
| Independent Living | 2 | 2021 | 579 | 0.260 |
Why?
|
| Self Report | 3 | 2024 | 3725 | 0.260 |
Why?
|
| Tauopathies | 2 | 2019 | 320 | 0.250 |
Why?
|
| DNA Repeat Expansion | 1 | 2005 | 73 | 0.250 |
Why?
|
| Brain Diseases | 1 | 2014 | 1546 | 0.250 |
Why?
|
| Aged, 80 and over | 17 | 2024 | 58983 | 0.240 |
Why?
|
| Cognition | 6 | 2024 | 6992 | 0.230 |
Why?
|
| Bipolar Disorder | 4 | 2022 | 5092 | 0.210 |
Why?
|
| Ethylene Glycols | 3 | 2021 | 190 | 0.210 |
Why?
|
| Cross-Sectional Studies | 11 | 2024 | 26127 | 0.200 |
Why?
|
| Behavioral Symptoms | 1 | 2023 | 186 | 0.200 |
Why?
|
| Activities of Daily Living | 3 | 2023 | 2421 | 0.190 |
Why?
|
| Genomic Instability | 1 | 2005 | 709 | 0.190 |
Why?
|
| Anxiety | 3 | 2023 | 4573 | 0.180 |
Why?
|
| Humans | 54 | 2024 | 761578 | 0.180 |
Why?
|
| Thiazoles | 5 | 2019 | 1517 | 0.170 |
Why?
|
| Hippocampus | 4 | 2023 | 3766 | 0.170 |
Why?
|
| Colombia | 4 | 2021 | 282 | 0.170 |
Why?
|
| Heterozygote | 3 | 2021 | 2787 | 0.160 |
Why?
|
| Neurofilament Proteins | 1 | 2021 | 336 | 0.160 |
Why?
|
| Male | 32 | 2024 | 360841 | 0.150 |
Why?
|
| Psychological Techniques | 1 | 2017 | 48 | 0.150 |
Why?
|
| Euphoria | 1 | 2017 | 65 | 0.150 |
Why?
|
| Female | 32 | 2024 | 392688 | 0.140 |
Why?
|
| Psychotic Disorders | 2 | 2022 | 3223 | 0.140 |
Why?
|
| Cerebellum | 3 | 2013 | 1501 | 0.130 |
Why?
|
| Mental Health | 2 | 2023 | 3250 | 0.130 |
Why?
|
| Irritable Mood | 1 | 2017 | 194 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 4 | 2011 | 4415 | 0.130 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2015 | 37 | 0.120 |
Why?
|
| Mutation | 5 | 2023 | 30054 | 0.120 |
Why?
|
| Dementia | 2 | 2022 | 2689 | 0.120 |
Why?
|
| Electroconvulsive Therapy | 1 | 2020 | 500 | 0.120 |
Why?
|
| Psychosomatic Medicine | 1 | 2015 | 71 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2005 | 1667 | 0.120 |
Why?
|
| Malnutrition | 1 | 2021 | 645 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2018 | 6019 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2019 | 1235 | 0.100 |
Why?
|
| Syphilis | 1 | 2015 | 243 | 0.100 |
Why?
|
| Antigens, Ly | 1 | 2013 | 295 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 3826 | 0.100 |
Why?
|
| Asymptomatic Diseases | 3 | 2019 | 588 | 0.090 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2011 | 150 | 0.090 |
Why?
|
| Radiopharmaceuticals | 2 | 2019 | 2651 | 0.090 |
Why?
|
| Lithium | 1 | 2013 | 596 | 0.090 |
Why?
|
| Hallucinations | 2 | 2022 | 366 | 0.080 |
Why?
|
| Nuclear Proteins | 3 | 2008 | 5799 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2023 | 4399 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 2897 | 0.080 |
Why?
|
| Middle Aged | 13 | 2023 | 220917 | 0.080 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2017 | 2010 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2023 | 8633 | 0.070 |
Why?
|
| Alleles | 1 | 2019 | 6864 | 0.070 |
Why?
|
| Psychometrics | 1 | 2017 | 3065 | 0.070 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 413 | 0.070 |
Why?
|
| Carbolines | 2 | 2019 | 296 | 0.070 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2008 | 247 | 0.070 |
Why?
|
| Purkinje Cells | 1 | 2008 | 226 | 0.070 |
Why?
|
| Lithium Carbonate | 1 | 2007 | 179 | 0.070 |
Why?
|
| Affective Symptoms | 2 | 2021 | 417 | 0.070 |
Why?
|
| Metabolome | 1 | 2013 | 989 | 0.070 |
Why?
|
| Atrophy | 2 | 2023 | 1633 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2023 | 12953 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5112 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2019 | 3728 | 0.070 |
Why?
|
| Life Style | 1 | 2017 | 3917 | 0.060 |
Why?
|
| Forecasting | 1 | 2014 | 2928 | 0.060 |
Why?
|
| Myotonic Dystrophy | 1 | 2005 | 78 | 0.060 |
Why?
|
| Friedreich Ataxia | 1 | 2005 | 77 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1749 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2008 | 23447 | 0.060 |
Why?
|
| Tobacco necrosis satellite virus | 1 | 2004 | 1 | 0.060 |
Why?
|
| Fragile X Syndrome | 1 | 2005 | 116 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-4F | 1 | 2004 | 42 | 0.060 |
Why?
|
| Education, Medical | 1 | 2015 | 1725 | 0.060 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 141 | 0.050 |
Why?
|
| Rheumatic Fever | 1 | 2003 | 73 | 0.050 |
Why?
|
| Antimanic Agents | 1 | 2007 | 520 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2022 | 6937 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18255 | 0.050 |
Why?
|
| Depressive Disorder, Major | 1 | 2020 | 4761 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 489 | 0.050 |
Why?
|
| Disease Progression | 4 | 2023 | 13510 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2023 | 151 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 13367 | 0.050 |
Why?
|
| Sleep | 1 | 2017 | 4768 | 0.050 |
Why?
|
| Obesity | 1 | 2023 | 12947 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2004 | 537 | 0.050 |
Why?
|
| Personality Tests | 1 | 2021 | 81 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17904 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2008 | 2919 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2008 | 11904 | 0.040 |
Why?
|
| Potassium | 1 | 2004 | 1311 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12973 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 66 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2008 | 9542 | 0.040 |
Why?
|
| Sex Factors | 2 | 2023 | 10554 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2003 | 1526 | 0.040 |
Why?
|
| Spouses | 1 | 2021 | 283 | 0.040 |
Why?
|
| Life Change Events | 1 | 2023 | 952 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2005 | 3968 | 0.040 |
Why?
|
| Risk | 2 | 2020 | 9610 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2021 | 41493 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2023 | 2601 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 2112 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7859 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2005 | 1088 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 22173 | 0.030 |
Why?
|
| Contrast Media | 2 | 2019 | 5307 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 74212 | 0.030 |
Why?
|
| Semantics | 1 | 2019 | 613 | 0.030 |
Why?
|
| RNA | 1 | 2005 | 2725 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 982 | 0.030 |
Why?
|
| Adult | 6 | 2021 | 221200 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2003 | 1668 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 14032 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1068 | 0.030 |
Why?
|
| Brazil | 1 | 2018 | 1230 | 0.030 |
Why?
|
| Peptides | 1 | 2005 | 4358 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15502 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 353 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 1648 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2008 | 3816 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2021 | 1615 | 0.030 |
Why?
|
| Mice | 5 | 2013 | 81539 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 36426 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2017 | 1139 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2022 | 2639 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 1443 | 0.020 |
Why?
|
| Teaching Rounds | 1 | 2015 | 275 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2011 | 257 | 0.020 |
Why?
|
| Calcium | 1 | 2003 | 5722 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 2629 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 1410 | 0.020 |
Why?
|
| Caregivers | 1 | 2022 | 2238 | 0.020 |
Why?
|
| Animals | 7 | 2013 | 168475 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3801 | 0.020 |
Why?
|
| Linear Models | 1 | 2019 | 5872 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 2220 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 2400 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9326 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3415 | 0.020 |
Why?
|
| Teaching | 1 | 2015 | 1170 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2007 | 53 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2007 | 107 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2023 | 54423 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2820 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 866 | 0.020 |
Why?
|
| Base Sequence | 2 | 2011 | 12441 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2008 | 366 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12990 | 0.020 |
Why?
|
| Learning | 1 | 2015 | 1740 | 0.020 |
Why?
|
| Emotions | 1 | 2017 | 2739 | 0.020 |
Why?
|
| Glutamine | 1 | 2008 | 577 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2020 | 6567 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 3848 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 483 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 411 | 0.020 |
Why?
|
| Neurons | 1 | 2004 | 9463 | 0.010 |
Why?
|
| Shal Potassium Channels | 1 | 2004 | 20 | 0.010 |
Why?
|
| Registries | 1 | 2020 | 8224 | 0.010 |
Why?
|
| Phosphorylation | 2 | 2007 | 8321 | 0.010 |
Why?
|
| Dendrites | 1 | 2007 | 475 | 0.010 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2004 | 40 | 0.010 |
Why?
|
| United States | 2 | 2023 | 72335 | 0.010 |
Why?
|
| Metabolomics | 1 | 2013 | 1659 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2011 | 2665 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2004 | 174 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2019 | 6237 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 813 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 460 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2065 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 427 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9319 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6075 | 0.010 |
Why?
|
| Xenopus | 1 | 2004 | 711 | 0.010 |
Why?
|
| Time Factors | 2 | 2017 | 39970 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 927 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2004 | 369 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 519 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18398 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8656 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1693 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5774 | 0.010 |
Why?
|
| Ribosomes | 1 | 2004 | 501 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 2423 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 902 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 1232 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2003 | 620 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1069 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 3430 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15936 | 0.010 |
Why?
|
| Oocytes | 1 | 2004 | 1166 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 1206 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1080 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 2457 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2004 | 18966 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14417 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2677 | 0.010 |
Why?
|
| Rats | 2 | 2004 | 23741 | 0.010 |
Why?
|
| Memory | 1 | 2007 | 2193 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23996 | 0.010 |
Why?
|
| Hypertension | 1 | 2017 | 8540 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 2715 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 3733 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2004 | 2846 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 4125 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 64684 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 2986 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8181 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59254 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 12794 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 17635 | 0.010 |
Why?
|
| Child | 1 | 2019 | 80157 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 88323 | 0.010 |
Why?
|